United Therapeutics (UTHR)

• Market cap: $13.8B
• 1 day: -0.34%
• 5 days: -1.98%
• 1 month: -4.09%
• 3 months: -14.17%
• 6 months: -14.34%
• Year to date: -14.78%
• 1 year: 33.63%
• 5 years: 216.24%
• 10 years: 73.62%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

122% more first-time investments, than exits

New positions opened: 100 | Existing positions closed: 45

41.92% more ownership

Funds ownership: 97.46% [Q3] → 139.38% (+41.92%) [Q4]

29% more repeat investments, than reductions

Existing positions increased: 265 | Existing positions reduced: 206

21% more call options, than puts

Call options by funds: $46M | Put options by funds: $37.9M

7% more funds holding

Funds holding: 617 [Q3] → 659 (+42) [Q4]

0% more capital invested

Capital invested by funds: $15.5B [Q3] → $15.5B (+$4.53M) [Q4]

29% less funds holding in top 10

Funds holding in top 10: 17 [Q3] → 12 (-5) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $425 38% upside
• Avg. target: $450 47% upside
• High target: $475 55% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Andrew Fein 31% 1-year accuracy 109 / 356 met price target	38% upside $425	Buy Reiterated	27 Feb 2025
UBS Ashwani Verma 22% 1-year accuracy 4 / 18 met price target	55% upside $475	Buy Maintained	8 Jan 2025